- British Patients Also Suffering From Dangerous Metal Hip Device
- June 18, 2015
- Law Firm: Waters Kraus LLP - Dallas Office
- Patients in the United Kingdom are experiencing the same problems with metal-on-metal hip replacements that those here in the United States are suffering. The manufacturers of one defective metal hip device called the ‘Birmingham Hip Modular Head total hip replacement’ (BHMH) have recently disclosed that their product is holding up much worse than was previously known. Smith & Nephew Orthopaedics Limited is the manufacture of the defective BHMH replacement hip device.
New Safety Notice From Metal Hip Maker in Britain Discloses Patients’ High Levels of Chromium and Cobalt in the Bloodstream and Unacceptable Risk of Replacement Hip Failure
In response to the revelation, the British Medicines & Healthcare Regulatory Agency (MHRA) has made public an Urgent Field Safety Notice from Smith & Nephew about the metal on metal hip replacement. MHRA is the agency in England that regulates the safety of medical devices and medicines.
The Urgent Field Safety Notice is the third that Smith & Nephew has released. In England, manufacturers are required to send out such notices to caution users about potential dangers associated with their devices. Smith & Nephew circulated the earlier warnings in October 2012 and May 2013. In 2014, the medical device maker reportedly phased out the BHMH device entirely.
A newly released clinical study in the United Kingdom reports that 43 percent of patients who received the BHMH implant were found to have high levels of chromium and cobalt in the bloodstream. In addition, it has been determined that the BHMH device has a failure rate after six years that is three times greater than England’s National Health Service deems acceptable.